Skip to main content
Journal of Pain Research logoLink to Journal of Pain Research
. 2020 Jul 27;13:1899–1900. doi: 10.2147/JPR.S272270

Low-Intensity Continuous Ultrasound for the Symptomatic Treatment of Upper Shoulder and Neck Pain: A Randomized, Double-Blind Placebo-Controlled Clinical Trial [Corrigendum]

PMCID: PMC7397472  PMID: 32801847

Petterson S, Plancher K, Klyve D, Draper D, Ortiz R. J Pain Res. 2020;13:1277—1287.

Page 1277, Abstract, Results, second sentence, the text “Participants treated with active therapy observed a significant mean pain reduction from baseline of 2.61 points for active (p<0.001), compared to 1.58 points decrease from baseline for placebo (p=0.087), resulting in a 1.03 points significant decrease in the active group over placebo (p=0.003)” should read “Participants treated with active therapy observed a significant mean pain reduction from baseline of 2.61 points for active (p<0.001), compared to 1.58 points decrease from baseline for placebo (p=0.087), resulting in a 1.03 points significant decrease in the active group over placebo (p=0.009)”.

Page 1281, Results, Pain Change from Baseline section, last sentence, the text “While this could indicate a placebo effect, the difference between groups for change from baseline was significant for all 4 weeks assessed (p<0.001 for weeks 1–3, p=0.003 for week 4), showing a more significant change from baseline for the active LICUS group compared to placebo” should read “While this could indicate a placebo effect, the difference between groups for change from baseline was significant for all 4 weeks assessed (p<0.001 for weeks 1–2, p<0.01 for weeks 3-4), showing a more significant change from baseline for the active LICUS group compared to placebo”.

Page 1282, Table 2 is incorrect. The correct table is shown below.

Table 2 Primary Outcomes. The Pain Reported at Baseline and Weekly Averages. Change in Pain from Baseline and Comparison Between Groups Evaluated Using Independent t-tests

Pain diary data (NRS)
Time Active Placebo Between Group Mean 95% CI P-value
Baseline 5.60 ± 1.58 5.44 ± 1.95 0.163 (-1.22 to 1.55) 0.81
Week 1 3.54 ± 1.64 4.58 ± 2.20 -1.03 (-1.65 to -0.42) 0.001
Week 2 3.26 ± 1.58 4.74 ± 2.39 -1.48 (-2.12 to -0.84) <0.001
Week 3 3.09 ± 1.54 3.92 ± 2.10 -0.827 (-1.46 to -0.19) 0.011
Week 4 2.98 ± 1.62 3.86 ± 2.30 -0.87 (-1.64 to -0.106) 0.026
NRS mean change from baseline 95% CI
Week 1 -2.05 ± 1.64 -0.860 ± 2.21 -1.20 (-1.81 to -0.579) <0.001
-2.76 to -1.35 -2.53 to 0.81
p<0.001 p=0.306
Week 2 -2.34 ± 1.59 -0.693 ± 2.38 -1.65 (-2.28 to -1.00) <0.001
-3.03 to -1.65 -2.49 to 1.11
p<0.001 p=0.443
Week 3 -2.51 ± 1.55 -1.52 ± 2.11 -0.989 (-1.62 to -0.351) 0.003
-3.18 to -1.83 -3.14 to 0.110
p<0.001 p=0.07
Week 4 -2.61 ± 1.63 -1.58 ± 2.30 -1.03 (-1.80 to -0.264) 0.009
-3.34 to -1.90 -3.40 to 0.24
p<0.001 p=0.087

The authors apologize for these errors and advise they do not affect the results of the paper.


Articles from Journal of Pain Research are provided here courtesy of Dove Press

RESOURCES